Organisation paid for research Program year 2024 Source: CMS Open Payments

Invesclinic US LLC

Neither a doctor nor a teaching hospital

Research payments

$5,128,861

225 payments

Through program year 2024, Invesclinic US LLC is reported as receiving $5,128,861 in research payments, across 225 payments.

By program year

6 rows

Year	Kind	Amount	Payments
2024	Research	$34,319	6
2023	Research	$74,277	15
2022	Research	$730,655	74
2021	Research	$4,054,715	87
2020	Research	$190,081	35
2019	Research	$44,814	8

Breakdown

Who paid Research payments · program years 2019–2024

Becton, Dickinson and Company $4,100,115 24 payments
Pfizer Inc. $391,834 51 payments
AbbVie, Inc. $280,313 50 payments
Bavarian Nordic A/S $182,086 17 payments
Gilead Sciences, Inc. $60,224 9 payments
Sanofi US Services Inc. $45,251 16 payments
Esperion Therapeutics, Inc. $18,324 44 payments
Boehringer Ingelheim Pharmaceuticals, Inc. $15,065 2 payments
Sanofi Pasteur Inc. $13,000 6 payments
Genentech, Inc. $8,750 3 payments

Studies the money was for Research payments · program years 2019–2024

Veritor Antigen Assay $2,045,170 5 payments
Veritor Pediatric Population $928,910 4 payments
Max Respiratory Panel COVID/FLU/RSV $506,790 5 payments
Covid BioSpec $222,076 4 payments
QuickSilverFlu $219,835 2 payments
A Phase 12 Randomized Study to Evaluate the Safety Tolerability and Immunogenicity of A Modified Rna Vaccine Against Influenza in Healthy Individuals $214,875 13 payments
Veritor LTC population $174,314 3 payments
Nct05238025 $169,131 16 payments
Phase 1 Openlabel Dosefinding Study to Evaluate Safety Tolerability and Immunogenicity and Phase 23 Placebocontrolled Observerblinded Safety Tolerability and Immunogenicity Study of A Sarscov2 Rna Vaccine Candidate Against Covid19 in Healthy Children and Young Adults $116,639 25 payments
M19-161 $87,205 8 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.